AAAP Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
0.00 (0.00 %)
(As of 02/20/2018)
Today's Range
50-Day Range N/A
52-Week Range
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A

Receive AAAP News and Ratings via Email

Sign-up to receive the latest news and ratings for AAAP and its competitors with MarketBeat's FREE daily newsletter.

AAAP logo

About AAAP

Advanced Accelerator Applications S.A. is a radiopharmaceutical company. The Company develops, produces and commercializes molecular nuclear medicine (MNM), diagnostic and therapeutic products. MNM uses trace amounts of radioactive compounds to create functional images of organs and lesions and to treat diseases, such as cancer. The Company has a portfolio of nine diagnostic positron emission tomography (PET) and single-photon emission computed tomography (SPECT) products. PET and SPECT are imaging techniques in molecular nuclear diagnostics (MND) with applications in clinical oncology, cardiology, neurology and inflammatory/infectious diseases. Its commercial products include Gluscan/Gluscan 500/Barnascan, FluoroChol, MIBITEC/Adamibi, DOPAVIEW, Leukokit, Neurolite, SomaKit and NETSPOT. Additional MND product candidates include Annexin V-128, a SPECT product candidate for the imaging of apoptotic and necrotic lesions with potential applications in a range of indications.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.68 out of 5 stars

Medical Sector

1674th out of 2,215 stocks

Pharmaceutical Preparations Industry

720th out of 869 stocks

Analyst Opinion: 0.0Community Rank: 3.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

AAAP (NASDAQ:AAAP) Frequently Asked Questions

What stocks does MarketBeat like better than AAAP?

Wall Street analysts have given AAAP a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AAAP wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were AAAP's earnings last quarter?

AAAP (NASDAQ:AAAP) announced its earnings results on Thursday, August, 31st. The company reported ($0.13) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of ($0.12) by $0.01. The firm earned $40.14 million during the quarter, compared to analyst estimates of $36.74 million.
View AAAP's earnings history

Who are AAAP's key executives?

AAAP's management team includes the following people:
  • Susanne Schaffert, Chairman of the Board
  • Stefano Buono, Chief Executive Officer (Age 52)
  • Heinz Mausli, Chief Financial Officer (Age 52)
  • Gerard Ber, Chief Operating Officer (Age 57)
  • Claude A. Hariton Ph.D., Head of Clinical Development (Age 59)
  • Maurizio Franco Mariani, Global Head of Pre-Clinical Research (Age 55)
  • Frederic Collet, Director
  • Augusto Lima, Director
  • Jessica Toepfer, Director
  • Kapil Dhingra, Independent Director (Age 58)

Who are some of AAAP's key competitors?

What other stocks do shareholders of AAAP own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AAAP investors own include Comerica (CMA), Honda Motor (HMC), Albemarle (ALB), Clinigen Group (CLIN), Directa Plus (DCTA), Editas Medicine (EDIT), First Hawaiian (FHB), Landec (LNDC), MGT Capital Investments (MGTI) and NII (NIHD).

When did AAAP IPO?

(AAAP) raised $76 million in an initial public offering (IPO) on Thursday, February 5th 2015. The company issued 5,400,000 shares at $13.00-$15.00 per share. Citigroup and Jefferies served as the underwriters for the IPO and Canaccord Genuity and JMP Securities were co-managers.

What is AAAP's stock symbol?

AAAP trades on the NASDAQ under the ticker symbol "AAAP."

What is AAAP's stock price today?

One share of AAAP stock can currently be purchased for approximately $81.63.

What is AAAP's official website?

The official website for AAAP is

Where are AAAP's headquarters?

AAAP is headquartered at 20 Rue Diesel, Saint Genis Pouilly I0, 01630.

How can I contact AAAP?

AAAP's mailing address is 20 Rue Diesel, Saint Genis Pouilly I0, 01630. The company can be reached via phone at 33-04-50-99-30-70 or via email at [email protected]

This page was last updated on 7/29/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.